Olink Holding AB (publ) (OLK): Price and Financial Metrics

Olink Holding AB (publ) (OLK): $22.03

-0.05 (-0.23%)

POWR Rating

Component Grades














  • Sentiment is the dimension where OLK ranks best; there it ranks ahead of 73.11% of US stocks.
  • The strongest trend for OLK is in Sentiment, which has been heading up over the past 177 days.
  • OLK's current lowest rank is in the Momentum metric (where it is better than 10.72% of US stocks).

OLK Stock Summary

  • OLK's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.34 -- higher than only 3.63% of US-listed equities with positive expected earnings growth.
  • OLINK HOLDING AB (PUBL)'s stock had its IPO on March 25, 2021, making it an older stock than merely 5.23% of US equities in our set.
  • OLK's price/sales ratio is 17.32; that's higher than the P/S ratio of 93.91% of US stocks.
  • If you're looking for stocks that are quantitatively similar to OLINK HOLDING AB (PUBL), a group of peers worth examining would be GNSS, KVHI, INVE, CRSR, and REFR.
  • Visit OLK's SEC page to see the company's official filings. To visit the company's web site, go to www.olink.com.

OLK Valuation Summary

  • OLK's price/earnings ratio is -71.2; this is 418.57% lower than that of the median Healthcare stock.
  • Over the past 20 months, OLK's price/earnings ratio has gone up 560.7.

Below are key valuation metrics over time for OLK.

Stock Date P/S P/B P/E EV/EBIT
OLK 2022-11-01 19.0 5.3 -71.2 -68.0
OLK 2022-10-31 19.2 5.3 -71.7 -68.5
OLK 2022-10-28 19.1 5.3 -71.5 -68.3
OLK 2022-10-27 19.1 5.3 -71.4 -68.1
OLK 2022-10-26 18.5 5.1 -69.0 -65.8
OLK 2022-10-25 19.1 5.3 -71.6 -68.4

OLK Stock Price Chart Interactive Chart >

Price chart for OLK

OLK Price/Volume Stats

Current price $22.03 52-week high $24.93
Prev. close $22.08 52-week low $8.39
Day low $21.80 Volume 42,400
Day high $22.55 Avg. volume 214,099
50-day MA $17.08 Dividend yield N/A
200-day MA $15.46 Market Cap 2.62B

Olink Holding AB (publ) (OLK) Company Bio

Olink Holding AB (publ) provides various products and services for academic, government, biopharmaceutical, biotechnology, and other institutions focused on life science research. Its products include Olink Explore for cardiovascular and metabolic diseases, oncology, neurology, or inflammation; Olink Target product line; and Olink Focus product line consists of custom developed solutions for customers that have identified a small number of proteins of interest to focus on.

OLK Latest News Stream

Event/Time News Detail
Loading, please wait...

OLK Latest Social Stream

Loading social stream, please wait...

View Full OLK Social Stream

Latest OLK News From Around the Web

Below are the latest news stories about OLINK HOLDING AB (PUBL) that investors may wish to consider to help them evaluate OLK as an investment opportunity.

Zacks.com featured highlights MacroGenics, Olink Holding, NerdWallet, LiveRamp and LivePerson

MacroGenics, Olink Holding, NerdWallet, LiveRamp and LivePerson have been highlighted in this Screen of The Week article.

Yahoo | November 18, 2022

Maria Martin-Grau, at the University of Valencia, Spain is selected for the 2022 Novelties in Biomarkers award

UPPSALA, Sweden, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) is proud to announce the 2022 winner of the young researchers’ award, Novelties in Biomarkers, Maria Martin-Grau at the University of Valencia, Spain at the Biomarkers of the Future conference in Paris, France. Novelties in Biomarkers is an annual award established in 2019 by Olink Proteomics with the purpose of encouraging and motivating young scientists in the use of biomarker discovery in their research.

Yahoo | November 17, 2022

Wall Street Analysts Are Bullish on Top Healthcare Picks

There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Lantheus (LNTH – Research Report), Innate Pharma (IPHA – Research Report) and Olink Holding (OLK – Research Report) with bullish sentiments. Lantheus (LNTH) SVB Securities analyst Roanna Ruiz maintained a Buy rating on Lantheus today and set a price target of $120.00. The company's shares closed last Monday at $57.25. According to TipRanks.

Catie Powers on TipRanks | November 15, 2022

Announcing Olink® Flex, a new, unique and fully flexible low-plex proteomics solution using absolute quantification

UPPSALA, Sweden, Nov. 14, 2022 (GLOBE NEWSWIRE) -- Olink Holding AB (publ) (Nasdaq: OLK) today announced that it is now taking orders for Olink® Flex, a fully flexible made-to-order product to select and combine up to 21 human proteins using absolute quantification in one biomarker panel. With the introduction of Olink® Flex, the Company offers a mix-and-match solution for efficient creation of custom protein biomarker panels with uncompromised data quality, unparalleled specificity, high sensit

Yahoo | November 14, 2022

Olink Holding Third Quarter 2022 Earnings: Beats Expectations

Olink Holding ( NASDAQ:OLK ) Third Quarter 2022 Results Key Financial Results Revenue: US$31.8m (up 59% from 3Q 2021...

Yahoo | November 12, 2022

Read More 'OLK' Stories Here

OLK Price Returns

1-mo 20.71%
3-mo 37.86%
6-mo N/A
1-year -1.43%
3-year N/A
5-year N/A
YTD 21.04%
2021 N/A
2020 N/A
2019 N/A
2018 N/A
2017 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 1.5039 seconds.